stanozolol; androstanazol (Winstrol)
Jump to navigation
Jump to search
Introduction
Tradename: Winstrol. DEA-controlled substance: class 3.
Indications
Contraindications
Caution: avoid use in patients with severe hepatic insufficiency
Dosage
- adults:
- children:
Tabs: 2 mg.
Adjust dose with hepatic insufficiency.
Adverse effects
Male (postpubertal):
- common (> 10%)
- less common (1-10%)
- insomnia, chills, decreased libido, hepatic dysfunction, nausea, diarrhea, prostatic hypertrophy (elderly), iron-deficiency anemia, suppression of clotting factors
- uncommon (< 1%)
Male (prepubertal):
- common (> 10%)
- less common (1-10%)
- chills, insomnia, hyperpigmentation, diarrhea, nausea, iron-deficiency anemia, suppression of clotting factors
- uncommon (< 1%)
Female:
- common (> 10%)
- less common (1-10%)
- chills, insomnia, hypercalcemia, nausea, diarrhea, iron-deficiency anemia, suppression of clotting factors, hepatic dysfunction
- uncommon (< 1%)